Patent foramen ovale: indications for closure and techniques

Area of Science:

• Cardiology
• Neurology
• Vascular Medicine

Background:

• Non-surgical patent foramen ovale (PFO) closure is a well-established procedure with a strong safety record.
• Current indications for PFO closure are limited, often lacking robust randomized trial data.
• PFOs are implicated in paradoxical embolism, stroke, myocardial infarction, and other ischemic events, as well as migraine and sleep apnea.

Purpose of the Study:

• To evaluate the safety and efficacy of non-surgical PFO closure.
• To review the existing randomized data supporting PFO closure for specific conditions.
• To discuss the potential for expanded indications, including primary prevention.

Main Methods:

• Review of existing literature and randomized controlled trials on PFO closure.
• Analysis of data regarding PFO closure for secondary prevention of cerebral attacks and migraine.
• Discussion of the long-term safety and potential benefits of PFO closure.

Main Results:

• PFO closure has demonstrated a strong safety profile in approximately one million procedures worldwide.
• Randomized data, particularly for secondary prevention of stroke and migraine, show a numerical advantage for PFO closure.
• Sub-analyses in key trials indicate statistically significant benefits in specific patient subgroups.

Conclusions:

• Despite limited randomized data, the safety and potential benefits of PFO closure warrant consideration for broader application.
• The documented safety of PFO closure suggests a proactive approach in upcoming guidelines.
• The potential for primary prevention in high-risk PFO cases should be explored.